Bamco Inc. NY acquired a new position in Cognex Corporation (NASDAQ:CGNX - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,251,099 shares of the scientific and technical instruments company's stock, valued at approximately $90,605,000. Bamco Inc. NY owned approximately 0.74% of Cognex as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of CGNX. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Cognex in the 2nd quarter worth $26,000. Geneos Wealth Management Inc. increased its stake in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after buying an additional 736 shares during the period. Rakuten Securities Inc. bought a new stake in shares of Cognex in the second quarter valued at about $32,000. Elevation Wealth Partners LLC raised its holdings in shares of Cognex by 635.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company's stock valued at $35,000 after purchasing an additional 413 shares in the last quarter. Finally, CIBC Private Wealth Group LLC raised its stake in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company's stock worth $35,000 after buying an additional 327 shares in the last quarter. 88.12% of the stock is owned by institutional investors.
Cognex Trading Up 3.2%
Shares of NASDAQ:CGNX opened at $61.72 on Thursday. Cognex Corporation has a 12-month low of $34.60 and a 12-month high of $72.88. The company has a market capitalization of $10.38 billion, a PE ratio of 59.92 and a beta of 1.49. The business has a 50 day moving average of $64.60 and a two-hundred day moving average of $59.30.
Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.42 by $0.03. The business had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%.The business's quarterly revenue was up 16.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Equities research analysts predict that Cognex Corporation will post 1.68 earnings per share for the current fiscal year.
Cognex Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be given a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a yield of 0.6%. The ex-dividend date is Thursday, August 20th. Cognex's dividend payout ratio (DPR) is currently 33.01%.
Wall Street Analysts Forecast Growth
CGNX has been the subject of several analyst reports. Robert W. Baird set a $72.00 price target on shares of Cognex in a research report on Friday, May 8th. Cantor Fitzgerald lifted their price target on Cognex from $76.00 to $84.00 and gave the stock an "overweight" rating in a research report on Friday, August 7th. Needham & Company LLC lifted their price objective on shares of Cognex from $75.00 to $80.00 and gave the company a "buy" rating in a research note on Friday, August 7th. UBS Group set a $75.00 price objective on shares of Cognex in a report on Tuesday, May 26th. Finally, Citigroup reiterated a "neutral" rating and issued a $74.00 price objective (up from $72.00) on shares of Cognex in a research note on Friday, August 7th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $75.64.
Get Our Latest Analysis on Cognex
Cognex Profile
(
Free Report)
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.